watermark logo

4 Views· 29 August 2022

COVID-19 and Telogen Effluvium (Hair Loss)

Advertisement


djahyanmanette
Subscribers

Roger Seheult, MD of MedCram explains telogen effluvium hair loss. See all Dr. Seheult's videos at: https://www.medcram.com
(This video was recorded on March 25, 2022)

Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


LINKS / REFERENCES:

What is Hair Loss? (Maral) | https://www.maralhairklinik.com/what/

Hair Follicle (Wikipedia) | https://en.wikipedia.org/wiki/....Hair_follicle#Teloge

Telogen Effluviumn (Wikipedia) | https://en.wikipedia.org/wiki/Telogen_effluvium

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Lancet) | https://www.thelancet.com/jour....nals/lancet/article/

THE YEAR AMERICA’S HAIR FELL OUT (Atlantic) | https://www.theatlantic.com/he....alth/archive/2021/11


All coronavirus updates are at MedCram.com (including more discussion on new COVID variants, omicron variant, CDC, and more).


SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:

https://www.youtube.com/user/M....EDCRAMvideos?sub_con
Get notified of new videos by hitting the bell icon

MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


MEDIA CONTACT:

Media Contact: customers@medcram.com
Media contact info: https://www.medcram.com/pages/media-contact

Video Produced by Kyle Allred


FOLLOW US ON SOCIAL MEDIA:

https://www.facebook.com/MedCram
https://twitter.com/MedCramVideos
https://www.instagram.com/medcram


DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#COVID19 #Omicron #Coronavirus

Show more


Up next

Advertisement


0 Comments